位置:首页 > 蛋白库 > NFIX_HUMAN
NFIX_HUMAN
ID   NFIX_HUMAN              Reviewed;         502 AA.
AC   Q14938; B4DM25; O60413; Q0VG09; Q12859; Q13050; Q13052; Q5U094; Q9UPH1;
AC   Q9Y6R8;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 2.
DT   03-AUG-2022, entry version 196.
DE   RecName: Full=Nuclear factor 1 X-type;
DE            Short=NF1-X;
DE            Short=Nuclear factor 1/X;
DE   AltName: Full=CCAAT-box-binding transcription factor;
DE            Short=CTF;
DE   AltName: Full=Nuclear factor I/X;
DE            Short=NF-I/X;
DE            Short=NFI-X;
DE   AltName: Full=TGGCA-binding protein;
GN   Name=NFIX;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Foreskin;
RX   PubMed=7937100; DOI=10.1093/nar/22.19.3825;
RA   Apt D., Liu Y., Bernard H.U.;
RT   "Cloning and functional analysis of spliced isoforms of human nuclear
RT   factor I-X: interference with transcriptional activation by NFI/CTF in a
RT   cell-type specific manner.";
RL   Nucleic Acids Res. 22:3825-3833(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4 AND 5).
RC   TISSUE=Brain;
RX   PubMed=8799200; DOI=10.3109/13550289609146542;
RA   Sumner C., Shinohara T., Durham L., Traub R., Major E.O., Amemiya K.;
RT   "Expression of multiple classes of the nuclear factor-1 family in the
RT   developing human brain: differential expression of two classes of NF-1
RT   genes.";
RL   J. Neurovirol. 2:87-100(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-228.
RX   PubMed=7590749; DOI=10.1006/geno.1995.1107;
RA   Qian F., Kruse U., Lichter P., Sippel A.E.;
RT   "Chromosomal localization of the four genes (NFIA, B, C, and X) for the
RT   human transcription factor nuclear factor I by FISH.";
RL   Genomics 28:66-73(1995).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [10]
RP   INVOLVEMENT IN MALNS AND MRSHSS, TISSUE SPECIFICITY, AND DEVELOPMENTAL
RP   STAGE.
RX   PubMed=20673863; DOI=10.1016/j.ajhg.2010.07.001;
RA   Malan V., Rajan D., Thomas S., Shaw A.C., Louis Dit Picard H., Layet V.,
RA   Till M., van Haeringen A., Mortier G., Nampoothiri S., Puseljic S.,
RA   Legeai-Mallet L., Carter N.P., Vekemans M., Munnich A., Hennekam R.C.,
RA   Colleaux L., Cormier-Daire V.;
RT   "Distinct effects of allelic NFIX mutations on nonsense-mediated mRNA decay
RT   engender either a Sotos-like or a Marshall-Smith syndrome.";
RL   Am. J. Hum. Genet. 87:189-198(2010).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-265, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-280, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-279, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [14]
RP   9AATAD MOTIF.
RX   PubMed=31375868; DOI=10.1007/s00018-019-03251-w;
RA   Piskacek M., Havelka M., Jendruchova K., Knight A., Keegan L.P.;
RT   "The evolution of the 9aaTAD domain in Sp2 proteins: inactivation with
RT   valines and intron reservoirs.";
RL   Cell. Mol. Life Sci. 77:1793-1810(2020).
RN   [15]
RP   VARIANTS MALNS PRO-60 AND PRO-121.
RX   PubMed=22301465; DOI=10.1038/jhg.2012.7;
RA   Yoneda Y., Saitsu H., Touyama M., Makita Y., Miyamoto A., Hamada K.,
RA   Kurotaki N., Tomita H., Nishiyama K., Tsurusaki Y., Doi H., Miyake N.,
RA   Ogata K., Naritomi K., Matsumoto N.;
RT   "Missense mutations in the DNA-binding/dimerization domain of NFIX cause
RT   Sotos-like features.";
RL   J. Hum. Genet. 57:207-211(2012).
RN   [16]
RP   VARIANTS MALNS PRO-116 AND GLU-125.
RX   PubMed=26193383; DOI=10.1016/j.ejmg.2015.06.009;
RA   Gurrieri F., Cavaliere M.L., Wischmeijer A., Mammi C., Neri G.,
RA   Pisanti M.A., Rodella G., Lagana C., Priolo M.;
RT   "NFIX mutations affecting the DNA-binding domain cause a peculiar
RT   overgrowth syndrome (Malan syndrome): a new patients series.";
RL   Eur. J. Med. Genet. 58:488-491(2015).
RN   [17]
RP   INVOLVEMENT IN MRSHSS, AND VARIANTS MALNS CYS-38 AND PRO-54.
RX   PubMed=26200704; DOI=10.1038/pr.2015.135;
RA   Martinez F., Marin-Reina P., Sanchis-Calvo A., Perez-Aytes A., Oltra S.,
RA   Rosello M., Mayo S., Monfort S., Pantoja J., Orellana C.;
RT   "Novel mutations of NFIX gene causing Marshall-Smith syndrome or Sotos-like
RT   syndrome: one gene, two phenotypes.";
RL   Pediatr. Res. 78:533-539(2015).
CC   -!- FUNCTION: Recognizes and binds the palindromic sequence 5'-
CC       TTGGCNNNNNGCCAA-3' present in viral and cellular promoters and in the
CC       origin of replication of adenovirus type 2. These proteins are
CC       individually capable of activating transcription and replication.
CC   -!- SUBUNIT: Binds DNA as a homodimer.
CC   -!- INTERACTION:
CC       Q14938; Q2TAL8: QRICH1; NbExp=3; IntAct=EBI-8476987, EBI-2798044;
CC       Q14938; Q8N883: ZNF614; NbExp=3; IntAct=EBI-8476987, EBI-9675993;
CC       Q14938-3; P40763: STAT3; NbExp=3; IntAct=EBI-20559045, EBI-518675;
CC       Q14938-4; P40763: STAT3; NbExp=3; IntAct=EBI-20558886, EBI-518675;
CC       Q14938-5; P40692: MLH1; NbExp=3; IntAct=EBI-12024662, EBI-744248;
CC       Q14938-5; A0A0S2Z4H3: NFIB; NbExp=3; IntAct=EBI-12024662, EBI-16430952;
CC       Q14938-5; Q2TAL8: QRICH1; NbExp=3; IntAct=EBI-12024662, EBI-2798044;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC       Name=1;
CC         IsoId=Q14938-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q14938-2; Sequence=VSP_003560;
CC       Name=3;
CC         IsoId=Q14938-3; Sequence=VSP_003561, VSP_003562;
CC       Name=4;
CC         IsoId=Q14938-4; Sequence=VSP_003558;
CC       Name=5;
CC         IsoId=Q14938-5; Sequence=VSP_003559, VSP_003561, VSP_003562;
CC       Name=6;
CC         IsoId=Q14938-6; Sequence=VSP_003558, VSP_003561, VSP_003562;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:20673863}.
CC   -!- DEVELOPMENTAL STAGE: Prominent expression is observed in the central
CC       and peripheral nervous system in the embryo at Carnagie stage 17 (CS17;
CC       gestational day 42); at this stage it is also observed in the
CC       mandibular arch, cartilage primordium of the humerus, scapula, and
CC       vertebrae; in the limb expression is detected in the perichondrium.
CC       Expressed in the cerebral cortex, hippocampus, and faintly in the
CC       thalamus in fetal brain at 22 weeks of gestation,.
CC       {ECO:0000269|PubMed:20673863}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000269|PubMed:31375868}.
CC   -!- DISEASE: Malan syndrome (MALNS) [MIM:614753]: An autosomal dominant
CC       syndrome characterized by overgrowth, advanced bone age, macrocephaly,
CC       impaired intellectual development, behavior anomalies, and dysmorphic
CC       facial features. Patients develop marfanoid habitus, with long and
CC       slender body, very low body mass, long narrow face, and arachnodactyly.
CC       {ECO:0000269|PubMed:20673863, ECO:0000269|PubMed:22301465,
CC       ECO:0000269|PubMed:26193383, ECO:0000269|PubMed:26200704}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Marshall-Smith syndrome (MRSHSS) [MIM:602535]: A distinct
CC       malformation syndrome characterized by accelerated skeletal maturation,
CC       relative failure to thrive, respiratory difficulties, intellectual
CC       disability, and unusual facies, including prominent forehead, shallow
CC       orbits, blue sclerae, depressed nasal bridge, and micrognathia.
CC       Additional skeletal findings include long and thin tubular bones, broad
CC       middle phalanges with relatively narrow distal phalanges, and
CC       scoliosis. Inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:20673863, ECO:0000269|PubMed:26200704}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the CTF/NF-I family. {ECO:0000255|PROSITE-
CC       ProRule:PRU00436}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L31881; AAA53422.1; -; mRNA.
DR   EMBL; U18759; AAB52369.1; -; mRNA.
DR   EMBL; U18761; AAB52371.1; -; mRNA.
DR   EMBL; AK297261; BAG59737.1; -; mRNA.
DR   EMBL; BT019732; AAV38537.1; -; mRNA.
DR   EMBL; AC004660; AAC15752.1; -; Genomic_DNA.
DR   EMBL; AC007787; AAD38240.1; -; Genomic_DNA.
DR   EMBL; AC007787; AAD38241.1; -; Genomic_DNA.
DR   EMBL; CH471106; EAW84340.1; -; Genomic_DNA.
DR   EMBL; BC117113; AAI17114.1; -; mRNA.
DR   EMBL; BC117115; AAI17116.1; -; mRNA.
DR   EMBL; U07811; AAA93126.1; -; mRNA.
DR   CCDS; CCDS45996.1; -. [Q14938-3]
DR   CCDS; CCDS59359.1; -. [Q14938-6]
DR   PIR; S50112; S50112.
DR   RefSeq; NP_001257973.1; NM_001271044.2. [Q14938-6]
DR   RefSeq; NP_002492.2; NM_002501.3. [Q14938-3]
DR   RefSeq; XP_005259975.1; XM_005259918.4.
DR   AlphaFoldDB; Q14938; -.
DR   BioGRID; 110856; 196.
DR   IntAct; Q14938; 173.
DR   MINT; Q14938; -.
DR   STRING; 9606.ENSP00000380781; -.
DR   GlyGen; Q14938; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; Q14938; -.
DR   PhosphoSitePlus; Q14938; -.
DR   BioMuta; NFIX; -.
DR   DMDM; 14195678; -.
DR   EPD; Q14938; -.
DR   jPOST; Q14938; -.
DR   MassIVE; Q14938; -.
DR   MaxQB; Q14938; -.
DR   PaxDb; Q14938; -.
DR   PeptideAtlas; Q14938; -.
DR   PRIDE; Q14938; -.
DR   ProteomicsDB; 60247; -. [Q14938-1]
DR   ProteomicsDB; 60248; -. [Q14938-2]
DR   ProteomicsDB; 60249; -. [Q14938-3]
DR   ProteomicsDB; 60250; -. [Q14938-4]
DR   ProteomicsDB; 60251; -. [Q14938-5]
DR   Antibodypedia; 7151; 141 antibodies from 26 providers.
DR   DNASU; 4784; -.
DR   Ensembl; ENST00000397661.6; ENSP00000380781.2; ENSG00000008441.19. [Q14938-3]
DR   Ensembl; ENST00000585575.5; ENSP00000468794.1; ENSG00000008441.19. [Q14938-4]
DR   Ensembl; ENST00000587260.1; ENSP00000467785.1; ENSG00000008441.19. [Q14938-5]
DR   Ensembl; ENST00000587760.5; ENSP00000466389.1; ENSG00000008441.19. [Q14938-6]
DR   Ensembl; ENST00000592199.6; ENSP00000467512.1; ENSG00000008441.19. [Q14938-1]
DR   GeneID; 4784; -.
DR   KEGG; hsa:4784; -.
DR   MANE-Select; ENST00000592199.6; ENSP00000467512.1; NM_001365902.3; NP_001352831.1.
DR   UCSC; uc002mwd.4; human. [Q14938-1]
DR   CTD; 4784; -.
DR   DisGeNET; 4784; -.
DR   GeneCards; NFIX; -.
DR   HGNC; HGNC:7788; NFIX.
DR   HPA; ENSG00000008441; Tissue enhanced (skeletal).
DR   MalaCards; NFIX; -.
DR   MIM; 164005; gene.
DR   MIM; 602535; phenotype.
DR   MIM; 614753; phenotype.
DR   neXtProt; NX_Q14938; -.
DR   OpenTargets; ENSG00000008441; -.
DR   Orphanet; 447980; 19p13.3 microduplication syndrome.
DR   Orphanet; 420179; Malan overgrowth syndrome.
DR   Orphanet; 561; Marshall-Smith syndrome.
DR   PharmGKB; PA31594; -.
DR   VEuPathDB; HostDB:ENSG00000008441; -.
DR   eggNOG; KOG3663; Eukaryota.
DR   GeneTree; ENSGT00950000182916; -.
DR   InParanoid; Q14938; -.
DR   OMA; NDVDAGM; -.
DR   OrthoDB; 967862at2759; -.
DR   PhylomeDB; Q14938; -.
DR   TreeFam; TF313889; -.
DR   PathwayCommons; Q14938; -.
DR   Reactome; R-HSA-73980; RNA Polymerase III Transcription Termination.
DR   Reactome; R-HSA-749476; RNA Polymerase III Abortive And Retractive Initiation.
DR   SignaLink; Q14938; -.
DR   SIGNOR; Q14938; -.
DR   BioGRID-ORCS; 4784; 15 hits in 1102 CRISPR screens.
DR   ChiTaRS; NFIX; human.
DR   GeneWiki; NFIX; -.
DR   GenomeRNAi; 4784; -.
DR   Pharos; Q14938; Tbio.
DR   PRO; PR:Q14938; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q14938; protein.
DR   Bgee; ENSG00000008441; Expressed in cortical plate and 186 other tissues.
DR   ExpressionAtlas; Q14938; baseline and differential.
DR   Genevisible; Q14938; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0006260; P:DNA replication; IEA:UniProtKB-KW.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   InterPro; IPR000647; CTF/NFI.
DR   InterPro; IPR020604; CTF/NFI_DNA-bd-dom.
DR   InterPro; IPR019739; CTF/NFI_DNA-bd_CS.
DR   InterPro; IPR019548; CTF/NFI_DNA-bd_N.
DR   InterPro; IPR003619; MAD_homology1_Dwarfin-type.
DR   PANTHER; PTHR11492; PTHR11492; 1.
DR   Pfam; PF00859; CTF_NFI; 1.
DR   Pfam; PF03165; MH1; 1.
DR   Pfam; PF10524; NfI_DNAbd_pre-N; 1.
DR   SMART; SM00523; DWA; 1.
DR   PROSITE; PS00349; CTF_NFI_1; 1.
DR   PROSITE; PS51080; CTF_NFI_2; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Disease variant; DNA replication;
KW   DNA-binding; Isopeptide bond; Methylation; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..502
FT                   /note="Nuclear factor 1 X-type"
FT                   /id="PRO_0000100203"
FT   DNA_BIND        1..194
FT                   /note="CTF/NF-I"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00436"
FT   REGION          264..320
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          411..474
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           398..406
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000269|PubMed:31375868"
FT   COMPBIAS        301..315
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        411..425
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        430..445
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        448..474
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         265
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:23186163"
FT   MOD_RES         280
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:24275569"
FT   MOD_RES         288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70257"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70257"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P70257"
FT   MOD_RES         343
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P70257"
FT   MOD_RES         390
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P70257"
FT   CROSSLNK        279
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0007744|PubMed:28112733"
FT   VAR_SEQ         1..9
FT                   /note="MYSPYCLTQ -> M (in isoform 4 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:8799200"
FT                   /id="VSP_003558"
FT   VAR_SEQ         1..8
FT                   /note="MYSPYCLT -> MLPACRL (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:8799200"
FT                   /id="VSP_003559"
FT   VAR_SEQ         318..359
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7937100"
FT                   /id="VSP_003560"
FT   VAR_SEQ         419..441
FT                   /note="PNGSGQGKVPGSFLLPPPPPVAR -> HSQRQAPPLPTGLSASDPGTATF
FT                   (in isoform 3, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8799200,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_003561"
FT   VAR_SEQ         442..502
FT                   /note="Missing (in isoform 3, isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:8799200,
FT                   ECO:0000303|Ref.4"
FT                   /id="VSP_003562"
FT   VARIANT         38
FT                   /note="R -> C (in MALNS)"
FT                   /evidence="ECO:0000269|PubMed:26200704"
FT                   /id="VAR_077571"
FT   VARIANT         54
FT                   /note="R -> P (in MALNS)"
FT                   /evidence="ECO:0000269|PubMed:26200704"
FT                   /id="VAR_077572"
FT   VARIANT         60
FT                   /note="L -> P (in MALNS; dbSNP:rs387907254)"
FT                   /evidence="ECO:0000269|PubMed:22301465"
FT                   /id="VAR_068720"
FT   VARIANT         116
FT                   /note="R -> P (in MALNS)"
FT                   /evidence="ECO:0000269|PubMed:26193383"
FT                   /id="VAR_077573"
FT   VARIANT         121
FT                   /note="R -> P (in MALNS; dbSNP:rs387907255)"
FT                   /evidence="ECO:0000269|PubMed:22301465"
FT                   /id="VAR_068721"
FT   VARIANT         125
FT                   /note="K -> E (in MALNS)"
FT                   /evidence="ECO:0000269|PubMed:26193383"
FT                   /id="VAR_077574"
FT   CONFLICT        91
FT                   /note="F -> Y (in Ref. 1; AAA53422)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        399
FT                   /note="S -> P (in Ref. 3; BAG59737)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   502 AA;  55098 MW;  55B40A7DC505EA21 CRC64;
     MYSPYCLTQD EFHPFIEALL PHVRAFSYTW FNLQARKRKY FKKHEKRMSK DEERAVKDEL
     LGEKPEIKQK WASRLLAKLR KDIRPEFRED FVLTITGKKP PCCVLSNPDQ KGKIRRIDCL
     RQADKVWRLD LVMVILFKGI PLESTDGERL YKSPQCSNPG LCVQPHHIGV TIKELDLYLA
     YFVHTPESGQ SDSSNQQGDA DIKPLPNGHL SFQDCFVTSG VWNVTELVRV SQTPVATASG
     PNFSLADLES PSYYNINQVT LGRRSITSPP STSTTKRPKS IDDSEMESPV DDVFYPGTGR
     SPAAGSSQSS GWPNDVDAGP ASLKKSGKLD FCSALSSQGS SPRMAFTHHP LPVLAGVRPG
     SPRATASALH FPSTSIIQQS SPYFTHPTIR YHHHHGQDSL KEFVQFVCSD GSGQATGQPN
     GSGQGKVPGS FLLPPPPPVA RPVPLPMPDS KSTSTAPDGA ALTPPSPSFA TTGASSANRF
     VSIGPRDGNF LNIPQQSQSW FL
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024